Keywords: شش; coronary artery bypass grafting; percutaneous coronary intervention; coronary stenting; left main disease; Bio-ES; Biolimus-eluting stent; BMS; bare metal stent; CABG; coronary artery bypass grafting; CrI; credible interval; DES; drug-eluting stent; EES;
مقالات ISI شش (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شش; ACS; acute coronary syndrome; BP-BES; biolimus-eluting stent with biodegradable polymer; DES; drug-eluting stent; EES; everolimus-eluting stent; O-SES; Orsiro sirolimus-eluting stent; PCI; percutaneous coronary intervention; RCT; randomized controlled tri
Keywords: شش; BES; Biolimus eluting stent; BP-BES; Biolimus eluting stent with biodegradable polymer coating; BP-SES; Sirolimus eluting stent with biodegradable polymer coating; DES; Drug-eluting stent; EES; Everolimus eluting stent; GSI; Grey scale intensity; ISAR; In
Keywords: شش; ACS; acute coronary syndrome; BARC; Bleeding Academic Research Consortium; BMS; Bare metal stent; BP-BES; biodegradable polymer coated biolimus-A9 eluting stents; BP-SES; biodegradable polymer coated sirolimus eluting stents; BVS; bioresorbable vascular s
Keywords: شش; HGDP; handheld gamma detection probe; 111In; indium-111; LFOVGC; large field of view gamma camera; NET; neuroendocrine tumor; SPECT; single-photon emission CT; ZES; Zollinger-Ellison syndrome;
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents
Keywords: شش; DES; long-term outcome; newer-generation drug-eluting stent(s); PCI; percutaneous coronary intervention; PROMUS Element everolimus-eluting stent(s); Resolute Integrity zotarolimus-eluting stent(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter
Keywords: شش; drug-eluting stent(s); percutaneous coronary intervention; reference vessel diameter; Resolute Onyx; restenosis; stent(s); zotarolimus; DES; drug-eluting stent(s); MACE; major adverse cardiac event(s); MI; myocardial infarction; PCI; percutaneous coronary
Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial
Keywords: شش; BMS; bare-metal stents; CAC; coronary artery calcification; CAD; coronary artery disease; DES; drug-eluting stents; IVUS; intravascular ultrasound; MACE; major adverse cardiovascular events; MI; myocardial infarction; OA; orbital atherectomy; OAD; orbital
Safety and efficacy of everolimus-eluting stent versus zotarolimus-eluting stent: A meta-analysis of randomized controlled clinical trials and observational studies
Keywords: شش; EES; everolimus-eluting stent; ZES; zotarolimus-eluting stent; RCTs; randomized controlled clinical trials; MACE; major adverse cardiac events; MI; myocardial infarction; ST; stent thrombosis; TVR; target vessel revascularization; TLR; target lesion revas
The Zollinger-Ellison Syndrome: Dangers and Consequences of Interrupting Antisecretory Treatment
Keywords: شش; Gastrinoma; Regulatory Peptides; Gastrointestinal Hormones; Neuroendocrine Tumor; BAO; basal acid output; IV; intravenous; PPI; proton pump inhibitor; ZES; Zollinger-Ellison syndrome;
Diagnosis of the Zollinger-Ellison Syndrome
Keywords: شش; BAO; basal acid output; MEN-1; multiple endocrine neoplasia syndrome type 1; PPI; proton pump inhibitor; ZES; Zollinger-Ellison syndrome;
Importance of Surveillance for Multiple Endocrine Neoplasia-1 and Surgery in Patients With Sporadic Zollinger-Ellison Syndrome
Keywords: شش; Neuroendocrine Tumor; Gastrinoma; Survival Analysis; Management Strategy; CI; confidence interval; GAH; gastric acid hypersecretion; HR; hazard ratio; HUP; Hospital of the University of Pennsylvania; MEN-1; multiple endocrine neoplasia type 1; NIH; Nation
The Zollinger-Ellison Syndrome and Mismeasurement of Gastrin
Keywords: شش; Diagnostic Assays; Gastrinoma; Antibody; Gastrin Quantitation; CT; computed tomography; ELISA; enzyme-linked immunosorbent assay; RIA; radioimmunoassay; ZES; Zollinger-Ellison syndrome;
Duodenal gastrinoma treated with endoscopic band ligation
Keywords: شش; EBD; endoscopic balloon dilatation; EBL; endoscopic band ligation; GERD; gastroesophageal reflux disease; SMT; submucosal tumor; UGI; upper gastrointestinal; ZES; Zollinger-Ellison syndrome;
Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice
Keywords: شش; coronary artery lesion; drug-eluting stent; multicenter registry; restenosis; stent thrombosis; ARC; Academic Research Consortium; BMS; bare-metal stent(s); CEC; clinical events committee; CK-MB; creatine kinase-myocardial band; DES; drug-eluting stent(s)
Validation of a New Endoscopic Technique to Assess Acid Output in Zollinger-Ellison Syndrome
Keywords: شش; AC; acid concentration; AO; acid output; EGA; endoscopic gastric analysis; GA; gastric analysis; PPI; proton pump inhibitor; VO; volume output; ZES; Zollinger-Ellison Syndrome;
Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: A 13-year prospective study
Keywords: شش; BAO; basal acid output; B-I; Billroth I; B-II; Billroth II; BMI; body mass index; BPO; basal pepsin output; CI; confidence interval; DU; duodenal ulcer; H2RA; histamine 2 receptor antagonist; JU; jejunal ulcer; LESP; lower esophageal sphincter pressure; M
Precursor Lesions in Patients With Multiple Endocrine Neoplasia Type 1--Associated Duodenal Gastrinomas
Keywords: شش; CgA; chromogranin A; DGGE; denaturing gradient gel electrophoresis; ECL; enterochromaffin-like; PCR; polymerase chain reaction; TBS; Tris-buffered saline; ZES; Zollinger-Ellison syndrome;
Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances
Keywords: شش; APUD; Amine precursor uptake and decarboxylation; CgA; chromogranin-A; GEP; gastroenteropancreatic; MEN-1; multiple endocrine neoplasia syndrome 1; NET; neuroendocrine tumor; PET; pancreatic endocrine tumor; SRS; somatostatin receptor scintigraphy; SST; s